• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肝脏疾病中的肝纤维化。

Liver fibrosis in paediatric liver diseases.

机构信息

Unit of Liver Research, Bambino Gesù Children's Hospital, IRCCS, P.le S. Onofrio 4, 00165 Rome, Italy.

出版信息

Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):259-68. doi: 10.1016/j.bpg.2011.02.008.

DOI:10.1016/j.bpg.2011.02.008
PMID:21497743
Abstract

Numerous paediatric liver diseases from different origins may be complicated by development of liver fibrosis and progression to cirrhosis. Although fibrogenesis, which represents a major driving force for the development of liver fibrosis, has common tracts whatever the aetiology, liver fibrosis has different histopathological patterns in paediatric liver disease. In these diseases management choices may depend upon the stage of liver fibrosis. Thus, the accurate estimation of histological pattern of liver fibrosis is important for the prevention of the subsequent complications. Liver biopsy has long been considered as a gold standard diagnostic method for assessing liver fibrosis. However, due to its several disadvantages, in the last decades alternative and accurate non-invasive means to estimate fibrosis are developed. In this review, we characterised the most frequent histological patterns of liver fibrosis in paediatric liver diseases. Furthermore, we describe use of liver biopsy in diagnosis and staging of liver fibrosis, list the alternative non-invasive techniques that have an emerging role in the assessment of liver fibrosis, and propose a management algorithm.

摘要

许多源自不同病因的儿科肝脏疾病可能会发展为肝纤维化和肝硬化。尽管纤维化是肝纤维化发展的主要驱动力,无论病因如何,都有共同的途径,但在儿科肝脏疾病中,肝纤维化具有不同的组织病理学模式。在这些疾病中,治疗选择可能取决于肝纤维化的阶段。因此,准确估计肝纤维化的组织学模式对于预防随后的并发症很重要。肝活检长期以来一直被认为是评估肝纤维化的金标准诊断方法。然而,由于其多种缺点,在过去几十年中,已经开发出了其他准确的非侵入性方法来估计纤维化。在这篇综述中,我们描述了儿科肝脏疾病中最常见的肝纤维化组织学模式。此外,我们还描述了肝活检在肝纤维化诊断和分期中的应用,列出了在评估肝纤维化方面具有新兴作用的替代非侵入性技术,并提出了一种管理算法。

相似文献

1
Liver fibrosis in paediatric liver diseases.儿童肝脏疾病中的肝纤维化。
Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):259-68. doi: 10.1016/j.bpg.2011.02.008.
2
[Clinical application of non-invasive diagnosis for hepatic fibrosis].[肝纤维化无创诊断的临床应用]
Korean J Hepatol. 2007 Jun;13(2):129-37.
3
Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.丙型肝炎评估:非侵入性纤维化标志物和/或肝活检。
Liver Int. 2009 Jan;29 Suppl 1:19-22. doi: 10.1111/j.1478-3231.2008.01940.x.
4
Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.肝纤维化和肝硬化的非侵入性诊断与监测
Best Pract Res Clin Gastroenterol. 2009;23(3):453-60. doi: 10.1016/j.bpg.2009.03.002.
5
Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.用于评估慢性肝病纤维化和疾病进展的侵入性和非侵入性方法。
Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):291-303. doi: 10.1016/j.bpg.2011.02.003.
6
Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology.肝纤维化的非侵入性测量:FibroScan在肝病学中的应用。
Scand J Gastroenterol Suppl. 2006(243):85-8. doi: 10.1080/00365520600664359.
7
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.简单的非侵入性纤维化评分系统可以可靠地排除非酒精性脂肪性肝病患者的晚期纤维化。
Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.
8
Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中脂肪性肝炎和肝纤维化进展的预测因素
Clin Liver Dis. 2009 Nov;13(4):591-606. doi: 10.1016/j.cld.2009.07.011.
9
How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?如何评估慢性丙型肝炎肝纤维化:血清标志物还是瞬时弹性成像与肝活检?
Liver Int. 2011 Jan;31 Suppl 1:13-7. doi: 10.1111/j.1478-3231.2010.02380.x.
10
Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.肝活检及肝纤维化血清标志物在非酒精性脂肪性肝病中的作用
Clin Liver Dis. 2007 Feb;11(1):25-35, viii. doi: 10.1016/j.cld.2007.02.004.

引用本文的文献

1
Liver and systemic hemodynamics in cirrhotic children.肝硬化儿童的肝脏和全身血流动力学
World J Hepatol. 2025 Jul 27;17(7):103179. doi: 10.4254/wjh.v17.i7.103179.
2
Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy.儿童肝纤维化:机制、诊断与治疗的全面综述
Clin Exp Pediatr. 2023 Mar;66(3):110-124. doi: 10.3345/cep.2022.00367. Epub 2022 Dec 19.
3
A nomogram model based on preoperative grey-scale US features and routine serum biomarkers to predict the outcome of infants with biliary atresia after Kasai portoenterostomy.
基于术前灰阶超声特征和常规血清生物标志物的列线图模型,用于预测胆道闭锁婴儿Kasai肝门空肠吻合术后的结局。
Front Pediatr. 2022 Oct 20;10:972855. doi: 10.3389/fped.2022.972855. eCollection 2022.
4
Plasma amyloid-beta levels correlated with impaired hepatic functions: An adjuvant biomarker for the diagnosis of biliary atresia.血浆β淀粉样蛋白水平与肝功能受损相关:一种用于诊断胆道闭锁的辅助生物标志物。
Front Surg. 2022 Sep 5;9:931637. doi: 10.3389/fsurg.2022.931637. eCollection 2022.
5
Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis.用于胆道闭锁诊断及葛西肝门空肠吻合术后预后评估的生物标志物:一项系统综述与荟萃分析
Sci Rep. 2021 Jun 3;11(1):11692. doi: 10.1038/s41598-021-91072-y.
6
A Nomogram Predicting the Prognosis of Children With Biliary Atresia After Hepatoportoenterostomy.一种预测肝门空肠吻合术后胆道闭锁患儿预后的列线图。
Front Pediatr. 2021 Feb 24;9:641318. doi: 10.3389/fped.2021.641318. eCollection 2021.
7
Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.新型肝疾病标志物与早产短面猴(Papio sp.)新生儿肝疾病的相关性研究
PLoS One. 2020 Mar 9;15(3):e0228985. doi: 10.1371/journal.pone.0228985. eCollection 2020.
8
Significance of growth differentiation factor 15 in chronic HCV patients.生长分化因子15在慢性丙型肝炎患者中的意义
J Genet Eng Biotechnol. 2017 Dec;15(2):403-407. doi: 10.1016/j.jgeb.2017.08.004. Epub 2017 Aug 12.
9
Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease.血清高尔基糖蛋白 73 是一种与 APRI 相当的标志物,可用于诊断肝病患儿的显著纤维化。
Sci Rep. 2018 Nov 13;8(1):16730. doi: 10.1038/s41598-018-34714-y.
10
Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.天冬氨酸氨基转移酶与血小板比值在诊断胆道闭锁婴儿肝纤维化及预测术后预后中的验证
World J Gastroenterol. 2015 May 21;21(19):5893-900. doi: 10.3748/wjg.v21.i19.5893.